Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gottlieb

Showing results (241-250 of 609) with videos related to

Pageof 61
Sort By:
Journal of Psoriasis and Psoriatic Arthritis|June 2, 2025
All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims AnalysisAlice B Gottlieb, Hannah Crooke Kwiatkowski, Juan Semeco, et al.
Current Medical Research and Opinion|September 14, 2010
Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trialArthur Kavanaugh, Alan Menter, Alan Mendelsohn, et al.
Journal of the American Academy of Dermatology|December 10, 2014
Treatment of coexistent psoriasis and lupus erythematosusSowmya Varada, Alice B Gottlieb, Joseph F Merola, et al.
Journal of Dermatological Science|March 1, 1990
Occlusive hydrocolloid dressings decrease keratinocyte population growth fraction and clinical scale and skin thickness in active psoriatic plaquesA B Gottlieb, L Staiano-Coico, S R Cohen, et al.
The British Journal of Dermatology|May 18, 2011
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasisA B Gottlieb, C Leonardi, F Kerdel, et al.
Plos One|August 8, 2015
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with PsoriasisAlice B Gottlieb, James G Krueger, Mia Sandberg Lundblad, et al.
Journal of the American Academy of Dermatology|September 10, 2003
Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: combined effects on epidermal and immunologic activationEmmilia Hodak, Alice B Gottlieb, Tsvi Segal, et al.
Journal of Drugs in Dermatology : JDD|August 3, 2007
An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefaceptMelissa A Magliocco, Ann Marie Lozano, Claudia Van Saders, et al.
Infection Control and Hospital Epidemiology|October 14, 2024
Assessing for race, ethnicity, and socioeconomic disparities in central line-associated bloodstream infection risk in a large academic health systemLindsey B Gottlieb, Radhika Prakash-Asrani, William Dube, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2Kristina C Duffin, Kim A Papp, Jerry Bagel, et al.
Pageof 61

Showing results (241-250 of 609) with videos related to

Sort By:
Pageof 61
Journal of Psoriasis and Psoriatic Arthritis|June 2, 2025
All-Cause Mortality is Higher in Generalized Pustular Psoriasis (GPP) than Plaque Psoriasis and the General Population: A US-Based Claims AnalysisAlice B Gottlieb, Hannah Crooke Kwiatkowski, Juan Semeco, et al.
Current Medical Research and Opinion|September 14, 2010
Effect of ustekinumab on physical function and health-related quality of life in patients with psoriatic arthritis: a randomized, placebo-controlled, phase II trialArthur Kavanaugh, Alan Menter, Alan Mendelsohn, et al.
Journal of the American Academy of Dermatology|December 10, 2014
Treatment of coexistent psoriasis and lupus erythematosusSowmya Varada, Alice B Gottlieb, Joseph F Merola, et al.
Journal of Dermatological Science|March 1, 1990
Occlusive hydrocolloid dressings decrease keratinocyte population growth fraction and clinical scale and skin thickness in active psoriatic plaquesA B Gottlieb, L Staiano-Coico, S R Cohen, et al.
The British Journal of Dermatology|May 18, 2011
Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasisA B Gottlieb, C Leonardi, F Kerdel, et al.
Plos One|August 8, 2015
First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with PsoriasisAlice B Gottlieb, James G Krueger, Mia Sandberg Lundblad, et al.
Journal of the American Academy of Dermatology|September 10, 2003
Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: combined effects on epidermal and immunologic activationEmmilia Hodak, Alice B Gottlieb, Tsvi Segal, et al.
Journal of Drugs in Dermatology : JDD|August 3, 2007
An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefaceptMelissa A Magliocco, Ann Marie Lozano, Claudia Van Saders, et al.
Infection Control and Hospital Epidemiology|October 14, 2024
Assessing for race, ethnicity, and socioeconomic disparities in central line-associated bloodstream infection risk in a large academic health systemLindsey B Gottlieb, Radhika Prakash-Asrani, William Dube, et al.
Journal of Drugs in Dermatology : JDD|March 17, 2017
Evaluation of the Physician Global Assessment and Body Surface Area Composite Tool for Assessing Psoriasis Response to Apremilast Therapy: Results from ESTEEM 1 and ESTEEM 2Kristina C Duffin, Kim A Papp, Jerry Bagel, et al.
Pageof 61